Johnathan Lancaster – Biography
Last update: February 1, 2026Executive profile
Johnathan was Senior Vice President & Head, Global Medical Affairs at Regeneron Pharmaceuticals, and Chief Medical Officer at Myriad Genetics. Johnathan Lancaster joined Truveta in 2026.
Johnathan Lancaster is currentlyPresident and Chief Scientific Officer at Truveta - View - Truveta org chart
Create your alert
to follow the career of Johnathan Lancaster.
Education
Johnathan Lancaster has a Fellow Degree in Gynecologic Oncology from Duke University and a PhD in molecular genetics from University of Wales.
They have also studied at Duke University :
Joel Fleck - Barclays Americas Investment
Lauren Hood - Bank of America
Shelley Bransten - Microsoft
Find more alumni from Duke University
They have also studied at University of Wales :
Find more alumni from University of Wales
More about Johnathan Lancaster
Do you need to know more about Johnathan Lancaster? More results.
Participate
Social media
- Johnathan Lancaster on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Johnathan Lancaster
The colleagues of Johnathan Lancaster
Company Colleagues
- At Truveta, Johnathan Lancaster has 32 colleagues including Terry Myerson (CEO & Director), Daniel Roth (Director)…
Industry Colleagues
- In the Healthcare industry, Johnathan Lancaster has 54,619 colleagues in 3,494 companies located in 59 countries. 39,470 executive movements have been recorded in the last 12 months. Learn more about Healthcare.
Report an error
Update the org chart details of Johnathan Lancaster.
Get in Touch
Here are a few tips for establishing great contacts.
